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Background: Maternal overweight, obesity and consequently the incidence of gestational diabetes are increasing
rapidly worldwide. The objective of the study was to assess the efficacy and cost-effectiveness of a combined diet
and physical activity intervention implemented before, during and after pregnancy in a primary health care setting
for preventing gestational diabetes, later type 2 diabetes and other metabolic consequences.
Methods: RADIEL is a randomized controlled multi-center intervention trial in women at high risk for diabetes
(a previous history of gestational diabetes or prepregnancy BMI ≥30 kg/m2). Participants planning pregnancy or in
the first half of pregnancy were parallel-group randomized into an intervention arm which received lifestyle counseling
and a control arm which received usual care given at their local antenatal clinics. All participants visited a study nurse
every three months before and during pregnancy, and at 6 weeks, 6 and 12 months postpartum. Measurements
and laboratory tests were performed on all participants with special focus on dietary and exercise habits and
metabolic markers.
Of the 728 women [mean age 32.5 years (SD 4.7); median parity 1 (range 0-9)] considered to be eligible for the study
235 were non-pregnant and 493 pregnant [mean gestational age 13 (range 6 to 18) weeks] at the time of enrollment.
The proportion of nulliparous women was 29.8% (n = 217). Out of all participants, 79.6% of the non-pregnant and
40.4% of the pregnant women had previous gestational diabetes and 20.4% of the non-pregnant and 59.6% of the
pregnant women were recruited because of a prepregnancy BMI ≥30 kg/m2. Mean BMI at first visit was 30.1 kg/m2
(SD 6.2) in the non-pregnant and 32.7 kg/m2 (SD 5.6) in the pregnant group.
Discussion: To our knowledge, this is the first randomized lifestyle intervention trial, which includes, besides
the pregnancy period, both the prepregnancy and the postpartum period. This study design also provides an
opportunity to focus upon the health of the next generation. The study is expected to produce novel information on
the optimal timing and setting of interventions and for allocating resources to prevent obesity and diabetes in
women of reproductive age.
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Over the past few decades, obesity has become a global
health challenge. In Finland, approximately every third par-
turient is overweight (body mass index (BMI) ≥ 25 kg/m2)
and 13% are obese (BMI ≥ 30 kg/m2) [1]. The obesity
epidemic among women of reproductive age has led to an
increasing incidence of gestational diabetes (GDM) [1,2].
Gestational diabetes increases the likelihood of various
perinatal complications, including fetal macrosomia [3-6].
Maternal obesity and GDM are independently associated
with perinatal complications. The combined adverse effect
of these two risk factors on the frequency of adverse ob-
stetric outcomes is greater than that of either one alone
[7-9]. A Swedish population-based study, which compared
the time periods 1991-1997 and 1998-2008, reported no
improvement in maternal and neonatal outcomes among
GDM patients [5].
Up to 10% of women with previous GDM are diag-
nosed with type 2 diabetes soon after delivery. During a
ten-year follow-up the risk may be as high as 70% [10].
Maternal obesity and hyperglycemia during pregnancy
increase also the offspring’s risk of developing diabetes
and obesity, promoting the intergenerational transmis-
sion of cardiometabolic disorders [11-14]. These obser-
vations underline the need for effective interventions
that reduce obesity and prevent GDM among women of
childbearing age.
Pregnant women may be particularly motivated to
make healthy lifestyle changes. Recent data show that
diet and exercise interventions may be successful in re-
ducing gestational weight gain in women with an in-
creased risk of developing GDM but their effects on the
incidence of GDM and other adverse perinatal outcomes
have been limited [15-20]. The sample sizes in most of
these previous studies have been small. Furthermore,
none of them included an intervention that started
before pregnancy. Prepregnancy body size may be a
stronger predictor for adverse obstetric and perinatal
outcomes than weight gain during pregnancy [16,21].
Since pregnancy is a relatively brief period in life, diet
and physical activity interventions should optimally be
initiated already before pregnancy and continue after
delivery to prevent the development of overt diabetes.
To date, only a few postpartum intervention studies in
women with previous GDM have been implemented with
promising results in the reduction of cardiometabolic risk
factors [22-24].
The Finnish Gestational Diabetes Prevention Study
(RADIEL) is a randomized lifestyle intervention trial tar-
geting women at high risk for diabetes when planning
pregnancy or in the first half of pregnancy. The study
was designed for a primary health care setting with the
main aim to assess the efficacy and cost-effectiveness of
a combined diet and physical activity intervention,implemented before, during and after pregnancy, in lim-
iting gestational weight gain, preventing GDM and later
type 2 diabetes, and reducing cardiovascular disease
risk factors. The first phase of the study, including a
12-month follow-up postpartum, was completed in January
2014. In the second phase, subjects in the RADIEL cohort,
including mothers, fathers and children, will be followed-
up until the child is 10 years of age. This article presents
the study design and methods of the first phase of the
study as well as the baseline characteristics of the study
population.
Methods
Study design and recruitment
The RADIEL-study is a multi-center randomized con-
trolled intervention trial carried out between the years
2008 and 2014 in the maternity hospitals of the Helsinki
metropolitan area (Helsinki University Central Hospital
(HUCH) Department of Obstetrics and Gynecology,
Kätilöopisto Maternity Hospital and Jorvi Hospital)
and in the South-Karelia Central Hospital (SKCH) in
Lappeenranta, in South-Eastern Finland.
Women with a previous history of GDM or a prepreg-
nancy BMI ≥ 30 kg/m2, either planning pregnancy or
pregnant at less than 20 + 0 weeks’ gestation, were eli-
gible for the study. The subjects were recruited using
newspaper and targeted social media notices, through
primary health care centers and antenatal clinics as well
as by personal invitation letters sent out based on hos-
pital registry.
Exclusion criteria were: age <18 years, diabetes diagnosed
before pregnancy, medications that influence glucose me-
tabolism (e.g. oral corticosteroids and metformin), multiple
pregnancies, physical disability, current substance abuse,
severe psychiatric disorders and significant difficulties to
co-operate (e.g. inadequate Finnish language skills). Mis-
carriage or fetal death after 22 + 0 weeks’ gestation was not
a dropout criterion but an outcome of pregnancy and the
mother was allowed to continue the follow-up.
The participants were randomized as described later
into the intervention arm or the control arm of the
study. All participants entered into the study voluntarily,
signed an informed consent form and were allowed to
discontinue at any point. The study complies with the
Declaration of Helsinki [25] and was approved by Ethical
Boards of HUCH (14 September 2006, Dnro 300/E9/06)
and SKCH (11 September 2008, Dnro M06/08). The proto-
col was registered at clinicaltrials.gov (IDr: NCT01698385).
Sample size and randomization
Sample size was calculated assuming a GDM incidence
of 30% in the control arm and 20% incidence in the
intervention arm. Using a two-sided significance level of
0.05 and a power of 80%, and assuming a dropout rate
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be sufficient. The sample size calculation was carried out
with NQuery Advisor (6.0) using a continuity corrected
chi-square test. Randomization was performed using
randomly permuted blocks. Each subject was random-
ized by dispensing the next sequentially numbered sub-
ject code and opening the corresponding code envelope
indicating the study arm to be assigned to the partici-
pant in question. The intervention and control arms
were randomized in a balanced fashion separately within
each study site.
Intervention
The participants visited the study nurse in the hospital
outpatient clinic every three months before and during
pregnancy, and at 6 weeks, 6 months and 12 months
postpartum.
In the intervention arm, the visits included structured
counseling on diet and exercise (see below). Counseling
was given by study nurses and nutritionists specifically
trained for their tasks. The following weight targets were
set: 5-10% weight loss before pregnancy was recom-
mended for women with a prepregnancy BMI ≥ 25 kg/m2
and no weight gain during the first two trimesters of preg-
nancy was recommended for women with a prepregnancy
BMI ≥ 30 kg/m2.
Participants in the control arm received basic dietary
and exercise information leaflets similar to those pro-
vided at primary health care centers at the time of en-
rollment. During pregnancy, they received usual health
education provided at their local antenatal clinic.
Dietary intervention
Dietary counseling was based on the national Finnish
nutritional guidelines [26,27]. “The plate model” used
during the counseling sessions refers to filling half a
plate with raw or cooked vegetables, one quarter with
starchy carbohydrates (e.g. potato, rice or pasta) and one
quarter with meat, fish, beans, eggs or other sources of
protein. The aim was to achieve a total energy (E) intake
of 1600-1800 kcal a day, with 40-50% of total energy
(E%) coming from carbohydrates, 30-40 E% from fats
and 20-25 E% from protein. The participants in the inter-
vention arm were encouraged to increase their intake of
vegetables, legumes, fruits and berries; whole grain and
fiber; low-fat dairy and vegetable fats. During the postpar-
tum period, breastfeeding and infant nutrition counseling
were also provided based on national recommendations
[26]. Every three months throughout the study, the partici-
pants filled in three-day food diaries, which were used both
as motivational and educational tools and as data collec-
tion instruments.
In addition to regular visit to the study nurse participants
took part in structured group visits to a nutritionist at themoment of enrollment in the study, during the first
trimester of pregnancy as well as at 6 and 12 months
postpartum. Additional individual visits were arranged
when needed e.g. in case the dietary or weight manage-
ment goals were not met or the study subject had special
dietary restrictions.
Exercise intervention
The aim of the physical activity counseling was to
achieve a minimum of 30 minutes of moderate intensity
exercise five times a week or 50 minutes three times a
week and to adopt an overall active lifestyle including
daily household physical activity and/or transportation
physical activity. Moderate intensity exercise was defined
as exercise during which the participant becomes at least
slightly out of breath and perspires but is still able to
talk or a level equaling 11-15 on Borg’s visual scale of
perceived exertion [28,29]. An individual exercise pro-
gram was planned for each participant during the coun-
seling visits. The program was modified during the
follow-up when needed. Participants received pedome-
ters as motivational tools. The recommendation was a
minimum of 10 000 steps a day. The participants had
possibility to attend guided exercise groups provided by
the municipalities or got ticket to e.g. public swimming
pools once a week free of charge. In case exercise goals
were not met, the study subjects were instructed to book
an appointment with the physical activity advisor. The
services by the municipal physical activity advisors were
provided free of charge to everyone who wanted to re-
ceive extra counseling on exercise. Physical activity log-
books were used both as motivational and educational
tools and as data collection instruments.
Outcomes
The incidence of GDM was the primary outcome of the
RADIEL study. GDM was defined as one or more patho-
logical glucose value in a 75 g two-hour oral glucose
tolerance test (OGTT) during pregnancy. The follow-
ing diagnostic thresholds were applied: fasting plasma
glucose ≥ 5.3 mmol/l, one hour value ≥ 10.0 mmol/l and
two hour value ≥ 8.6 mmol/l [30]. Dietary treatment was
initiated in the primary health care center immediately
after diagnosis of GDM. In case glucose values in home
measurements exceeded repeatedly 5.5 mmol/l before
breakfast or 7.8 mmol/l one hour after a meal, insulin
treatment was initiated [31].
Secondary outcomes were gestational weight gain and
maternal body mass index (BMI), insulin sensitivity,
achievement of dietary and physical activity goals, inci-
dence of preeclampsia, incidence of gestational hyper-
tension, mode of delivery, perinatal outcome, maternal
quality of life, cost-effectiveness of the intervention in
prevention of GDM and incidence of maternal type 2
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fined according to the criteria of the American College
of Obstetricians and Gynecologists (ACOG) i.e. systolic
blood pressure of ≥ 140 mm Hg or diastolic blood pres-
sure of ≥ 90 mm Hg occurring after 20 weeks of gesta-
tion in a previously normotensive woman combined
with new-onset proteinuria of ≥0.3 g/24 h [32,33]. Ges-
tational hypertension was defined similarly but without
the presence of proteinuria. Macrosomia was defined as
birth weight > 2.0 SD and small for gestational age as
birth weight < -2.0 SD using a Finnish standards adjusted
for sex and gestational age [34]. Neonatal hypoglycaemia
was defined as blood glucose <2.6 mmol/l in the first
48 hours of life.
The obstetric and perinatal records of each subject
were reviewed and maternal and neonatal diagnoses
confirmed by research physicians before analysis of end-
points was initiated.
Data collection
Height, weight, waist and hip circumference (if not
pregnant), resting blood pressure and heart rate were
measured at the time of enrollment in the study. Self-
reported prepregnancy weight was collected from mater-
nity care cards. Height and weight were measured in light
indoor clothing and without shoes on. Height was mea-
sured to the nearest 0.5 cm and weight to the nearest
0.1 kg. Blood pressure was measured from the right arm
while the subject was in the sitting position using a
sphygmomanometer.
Body mass index (BMI) was calculated as weight in ki-
lograms divided by height in meters squared (kg/m2).
Waist-hip-ratio was defined as waist circumference mea-
sured 2 cm above the umbilical level divided by the hip
circumference measured at the widest portion of the
buttocks. The same measurements were made at every
follow-up visit except for the waist and hip measure-
ments, which were not taken during pregnancy.
Laboratory tests performed in conjunction with the
visits included a 75 g 2-hour oral glucose tolerance test
(OGTT), measurements of fasting plasma glucose and
insulin, glycated hemoglobin (GHbA1c), total cholesterol,
low-density lipoprotein (LDL) and high-density lipopro-
tein (HDL) cholesterol and triglycerides, alanine trans-
aminase (ALAT), thyroid-stimulating hormone (TSH),
free thyroxin (T4) and high-sensitive C-reactive protein
(hsCRP) (Table 1). Blood samples for DNA extraction
and further genetic analyses were drawn. In case the
result of any laboratory test or other measurement per-
formed as part of the RADIEL trial follow-up was abnor-
mal, the participants were referred to the primary health
care centers.
Data on mode of delivery, blood loss during delivery,
duration of labor, perineal tears, gestational age at birth,birth weight and length, umbilical artery pH and acid-
base values, Apgar scores, lowest blood glucose values of
the newborn infant, perinatal complications and neo-
natal intensive care unit admission were obtained from
patient records. In addition, a sample of cord blood was
collected at birth.
Information on socioeconomic status, self-reported
morbidity, use of medication, perceived health status,
quality of life, family history of diabetes and hyperten-
sion, obstetric history, smoking, consumption of alcohol,
history of weight management and diet and exercise
habits during the past six months were collected with a
background questionnaire and an interview by a study
nurse. Before every follow-up visit participants com-
pleted a questionnaire assessing changes in diet and ex-
ercise habits after the previous visit. After delivery, the
questionnaires included also questions concerning deliv-
ery and breastfeeding. The 15D Questionnaire [35] for
the assessment of health-related quality of life (HRQoL)
and quality-adjusted life years (QALY) was completed
at the enrollment visit as well as during pregnancy
and post-partum follow up visits. A modified Edinburgh
Postnatal Depression Scale (EPDS) questionnaire [36] for
the assessment of depressive symptoms was used at the
moment of enrollment, on the first trimester visit and on
each visit after delivery.
Logbooks of food intake and physical activity were
collected at enrollment, during the first and third tri-
mester visits and one year after delivery. Three-day
food diaries were filled for two weekdays and one day
during the weekend before each visit. Physical activity
logbooks, including records on physical activity type,
frequency and intensity on Borg scale and pedometer
readings (intervention group), were filled daily for one
week at each time. Participants in the intervention
group were encouraged to use logbooks as motivational
tool between the visits.
Statistical analysis
Means, range and/or standard deviation (SD) were used
to describe continuous normally distributed data. Skew
continuous data were described using median and range.
Differences in means between the independent groups
were tested using Student’s t-test and in medians
using Mann-Whitney u-test. Cross-tabulated data was
analyzed with Pearson’s chi-square test. The limit for
significance was set equal to 0.05. Data analysis was car-
ried out using SPSS for Windows (Version 21) and Mac
(Version 20).
Results
Between February 2008 and November 2011, 788 women
were recruited into the study. Sixty women were excluded:
27 did not meet the inclusion criteria and 33 did not
Table 1 Data collection in The Finnish Gestational Diabetes Prevention Study (RADIEL)
Enrollment Prepregnancy
follow-up every
3 months
1st
trimester
2nd
trimester
3rd
trimester
Birth 6 weeks
after delivery
6 months
after delivery
12 months
after delivery
Questionnaires
Background- and progress
questionnaires
Socioeconomic status X X
Medical and obstetric
history
X
Self reported morbidity
and use of medication
X X X X X X X X
Smoking and alcohol
consumption
X X X X X X X X
Quality of life X X X X X X X X
Diet X X X X X X X X
Physical activity X X X X X X X X
EPDS X X X X X
15D X X X X X X X
Logbooks for food and
physical activity
X X X X
Physical measurements
Height X
Weight and BMI X X X X X X X X
Waist-hip ratio X X X X X
Resting blood pressure
and heart rate
X X X X X X X X
Laboratory tests
75 g 2-hour OGTT X X X X X
Glucose, insulin, GHbA1c
and hsCRP
X X X X X X X X
ALAT, lipids X X X
TSH and free T4 X X
DNA X
Spare blood for further
analyses
X X X X X X X X
Offspring
Birth weight and length X
Apgar score X
Cord-blood gas analysis
(pH)
X
Cord-blood sample (DNA) X
EPDS = Edinburgh Postnatal Depression Scale; BMI = body mass index; OGTT = oral glucose tolerance test; GHbA1c = glycated hemoglobin; hsCRP = high sensivity
C-reactive protein; ALAT = alanin transaminase; TSH = thyroid-stimulating hormone; T4 = thyroxin.
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women, 235 were non-pregnant and 493 pregnant
during the first study visit. In the non-pregnant and
pregnant groups, 79.6% (n = 187) and 40.4% (n = 199),
respectively, had a history of previous GDM. Pre-
pregnancy BMI ≥30 kg/m2 without a history of previousGDM was the recruitment criterion for 20.4% (n = 48)
of women in the non-pregnant group and for 59.6%
(n = 294) in the pregnant group (Figure 1). The history of
GDM was verified by hospital records in 98.4% of the
cases (n = 380). In six women, previous GDM was self-
reported. Women with a history of previous GDM were
Enrolled
N=788
Pregnant
N=493
Not pregnant
N=235
Excluded 
N=60
Ineligible: 27
Did not consent: 33
History of 
GDM
N=187
Intervention: 97
Control: 90
BMI ≥ 30
N=48
Intervention: 23
Control: 25
History of 
GDM
N=199
Intervention: 101
Control: 98
Prepregnancy
BMI ≥ 30
N=294
Intervention: 149
Control: 145
Figure 1 Flow chart of participant recruitment. GDM= gestational
diabetes, BMI = body mass index.
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their BMI being ≥30 kg/m2 (Table 2). Of the participants
with a history of GDM 35.3% (n = 66) in the non-pregnant
and 42.7% (n = 85) in the pregnant group were obese.
Baseline characteristics of the study groups are pre-
sented in Tables 3, 4 and 5. There were more nulliparous
women in the pregnant group (38.3%, n = 189) than in
the non-pregnant group (11.9%, n = 28) (p < 0.001). In
the non-pregnant group, 17.4% (n = 20) of women in the
control arm and 6.7% (n = 8) in the intervention arm
were nulliparous (p = 0.01). There were no other sig-
nificant differences in any of the tested variables be-
tween the intervention and the control arm. 28.6% of the
women (n = 208) reported some chronic disease, no signifi-
cant difference was observed between non-pregnant and
pregnant participants.Table 2 Baseline mean BMI and history of gestational diabete
Non-pregnant group
N BMI mean (SD)2
Previous GDM 187 28.6 (5.7)
No GDM history 48 36.0 (4.4)
BMI = body mass index; GDM = gestational diabetes.
*Mean weeks of gestation 13 (range 6 to 18).
1P-value based on Student’s t test.
2P-value based on Student’s t test on difference between participants with and withIn the pregnant group, the mean gestational age was
13 + 1 (range 5 + 5 to 18 + 3) weeks at the first visit to
the study nurse. 3.1% of these pregnancies (n = 15) were
initiated with an embryo transfer. Participants who had
had an embryo transfer underwent the same study proto-
col as the rest of the study population.
Discussion
The prevalence of overweight and obesity among women
of childbearing age is rapidly increasing. This is leading
to an increasing incidence of gestational diabetes and
other metabolic and obstetric complications. This rising
problem has led to a growing interest within the scien-
tific community to identify effective intervention mea-
sures in order to interrupt the vicious cycle of obesity
and adverse health outcomes among pregnant women.
Successful weight loss in high risk obese women is
known to have large impact on later risk of type 2 dia-
betes and cardiovascular diseases [37]. Weight control
during pregnancy may also decrease the risk of obesity
in long term [22,38]. However lifestyle changes are diffi-
cult to achieve and maintain due to both physiological
and behavioral factors. There are several reasons to be-
lieve that a timely intervention during an early, plastic
phase of fetal development may also lead to improved
lifelong health of the newborn [39-42].
To our knowledge, the RADIEL study is the first ran-
domized GDM prevention study that includes both the
prepregnancy and postpartum period. Intervention dur-
ing prepregnancy provides an opportunity to promote
healthy maternal dietary habits and weight manage-
ment before conception and during the early phases of
pregnancy. This might be important in terms of fetal pro-
gramming. The post-partum intervention might be sig-
nificant in terms of improving the next generation’s
health and nutrition. Most women in our study had a
family history of overweight or obesity and almost a third
had a family history of type 2 diabetes, which show that
they do belong to a high risk group and furthermore
underline the need to target the whole family when aiming
at diabetes prevention. Gestational weight gain is deter-
mined by a multitude of factors [43] of which maternal diet
and physical activity are considered to be the mosts by study group
Pregnant group* p Value1 Difference
between the groupsN BMI mean (SD)2
199 29.4 (6.2) 0.19
291 35.0 (3.9) 0.11
out previous GDM <0.001.
Table 3 Demographic and socioeconomic characteristics by study group
Study
population
Non-pregnant
group
Pregnant
group
p-Value
Difference between
groups
N = 728 N = 235 N = 493
Age, Mean (SD) years 32.5 (4.7) 32.8 (4.2) 32.4 (4.9) 0.271
Marital status, n (%) N = 722 N = 234 N = 487
Married/co-habiting 699 (96.8%) 230 (98.3%) 469 (96.1%)
Other 23 (3.2%) 4 (1.7%) 19 (3.9%)
0.122
Basic education, n (%) N = 720 N = 234 N = 486
Elementary school 165 (22.9%) 42 (17.9%) 123 (25.3%)
Part of high school 31 (4.3%) 15 (6.4%) 16 (3.3%)
High school diploma 514 (71.4%) 173 (73.9%) 341 (70.2%)
Other 10 (1.4%) 4 (1.7%) 6 (1.2%)
0.0492
Vocational education, n (%) N = 718 N = 232 N = 486
No professional education/ diploma/degree 76 (10.6%) 25 (10.8%) 51 (10.5%)
Vocational course/school or apprenticeship 236 (32.9%) 70 (30.2%) 166 (34.2%)
Vocational diploma/degree 174 (24.2%) 54 (23.3%) 120 (24.7%)
Academic degree 228 (31.8%) 83 (35.8%) 145 (29.8%)
Other 4 (0.6%) 0 (0.0%) 4 (0.8%)
0.342
Current work situation, n (%) N = 722 N = 234 N = 488
Full-time work 368 (51.0%) 75 (32.1%) 293 (60.0%)
Part-time work 70 (9.7%) 25 (10.7%) 45 (9.2%)
Housewife 191 (26.5%) 87 (37.2%) 104 (21.3%)
Unemployed 16 (2.2%) 4 (1.7%) 12 (2.5%)
Maternity leave 36 (5.0%) 29 (12.4%) 7 (1.4%)
Other 41 (5.7%) 14 (6.0%) 27 (5.5%)
<0.0012
Annual household income, n (%) N = 689 N = 226 N = 463
<20 000 euro/year 33 (4.8%) 9 (4.0%) 24 (5.2%)
20 001-50 000 251 (36.4%) 83 (36.7%) 168 (36.3%)
50 001-100 000 366 (53.1%) 116 (51.3%) 250 (54.0%)
>100 000 39 (5.7%) 18 (8.0%) 21 (4.5%)
0.282
1P-value based on Student’s t test.
2P-values based on Pearson’s χ2 test.
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the RADIEL study. Diet and exercise interventions are
generally considered to be safe in pregnant women [15,16].
In order to further improve the safety of the intervention,
the study nurses were midwives with strong expertise in
counseling pregnant women. Lifestyle intervention
methods have previously been successfully implemented in
the prevention of type 2 diabetes in non-pregnant individ-
uals at increased risk for type 2 diabetes [37].When the RADIEL study was planned, no previous
studies in this field existed. Taking into account the
limited information available, it was decided to collect
a wide range of phenotypic data at baseline but also
during the intervention in order to establish predic-
tors of successful intervention as well as modifying
factors. The study included women at high risk of de-
veloping GDM and therefore the RADIEL cohort is
not representative of all pregnant Finnish women.
Table 4 Baseline health characteristics by study group
Study
population
Non-pregnant
group
Pregnant
group
p value
Difference between
groups
Smoking status, n (%) N = 728 N = 235 N = 493
Non-smoker 678 (93.1%) 215 (91.5%) 463 (93.9%)
Smoking regularly 46 (6.3%) 18 (7.7%) 28 (5.7%)
Smoking occasionally 4 (0.5%) 2 (0.9%) 2 (0.4%)
0.441
Alcohol consumption, n (%) N = 719 N = 232 N = 487
None (0 portions a week) 567 (78.9%) 100 (43.1%) 467 (95.9%)
Less than 5 portions a week 143 (19.9%) 123 (53.0%) 20 (4.1%)
5-10 portions a week 7 (1.0%) 7 (3.0%) 0 (0.0%)
More than 10 but not more than 16 portions a week 2 (0.3%) 2 (0.9%) 0 (0.0%)
<0.0011
BMI (kg/m2) N = 725 N = 235 N = 490
Mean (SD) 31.9 (6.0) 30.1 (6.2) 32.7 (5.6) <0.0012
BMI grouping, n (%) N = 725 N = 235 N = 490
Underweight (< 18,5) 4 (0.6%) 2 (0.9%) 2 (0.4%)
Normal (18,5-24,9) 105 (14.5%) 57 (24.3%) 48 (9.8%)
Overweight (25,0-29,9) 132 (18.2%) 62 (26.4%) 70 (14.3%)
Moderately obese (30,0-34,9) 270 (37.2%) 62 (26.4%) 208 (42.4%)
Severely obese (35,0-39,9) 160 (22.1%) 36 (15.3%) 124 (25.3%)
Very severely obese (≥ 40,0 or more) 54 (7.4%) 16 (6.8%) 38 (7.8%)
<0.0011
Pre-pregnancy BMI (kg/m2) N = 492
Mean (SD) 32.2 (5.8)
Pre-pregnancy BMI grouping n (%) N = 492
Underweight (less than 18,5) 2 (0.4%)
Normal (18,5-24,9) 66 (13.4%)
Overweight (25,0-29,9) 59 (12.0%)
Moderately obese (30,0-34,9) 222 (45.1%)
Severely obese (35,0-39,9) 107 (21.7%)
Very severely obese (40,0 or more) 36 (7.3%)
Parental history of diabetes or cardiovascular disease, n (%) N = 705 N = 229 N = 476
No 263 (37.3%) 82 (35.8%) 181 (38.0%)
Yes 442 (62.7%) 147 (64.2%) 295 (62.0%)
Type I diabetes 10 (1.4%) 2 (0.9%) 8 (1.7%) 0.401
Type II diabetes 197 (27.9%) 69 (30.1%) 128 (26.9%) 0.371
Hypertension 351 (49.8%) 114 (49.8%) 237 (49.8%) 1.001
Coronary artery disease 88 (12.5%) 30 (13.1%) 58 (12.2%) 0.731
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Table 4 Baseline health characteristics by study group (Continued)
N = 714 N = 232 N = 482
Parental history of overweight or obesity, n (%) 527 (73.8%) 172 (74.1%) 355 (73.7%) 0.891
Maternal overweight or obesity, n (%) N = 702 N = 229 N = 473
Yes 386 (55.0%) 123 (53.7%) 263 (55.6%)
Yes, before, but not any more 1 (0.1%) 1 (0.4%) 0 (0.0%)
No 315 (44.9%) 105 (45.9%) 210 (44.4%) 0.331
Paternal overweight or obesity, n (%) N = 697 N = 225 N = 472
Yes 332 (47.6%) 114 (50.7%) 218 (46.2%)
Yes, before, but not any more 9 (1.3%) 0 (0.0%) 9 (1.9%)
No 356 (51.1%) 111 (49.3%) 245 (51.9%) 0.081
BMI = body mass index.
1P-values based on Pearson’s χ2 test.
2P-value based on Student’s t test.
3p value based on Mann-Whitney U test.
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applying life style intervention, the control group is not a
true control group since they also received general infor-
mation about a healthy lifestyle. This might affect the
overall results.
In our study population, there are significantly more
nulliparous women in the pregnant group than in the
non-pregnant group. This was the result of the recruit-
ment methods used. Women in the non-pregnant group
were recruited mainly by personal invitation letters
based on hospital registry of previous GDM diagnosis.Table 5 Participants’ pregnancy history by study group
Study
population
N = 728
Median numbers of pregnancies (min-max) 1 (0-12)
Parity median (min-max) 1 (0-9)
History of pregnancy complications, n (%) N = 511
History of gestational diabetes 38 (75,5%)
Gestational diabetes treated with medication 56 (11,0%)
History of preeclampsia 43 (8,4%)
History of caesarian section 157 (30,7%)
History of preterm birth 23 (4,5%)
Birth weight of children, n (%) N = 500
Mothers with macrosomic babies (4500 g or more) 42 (8,4%)
Mothers with small babies (less than 2500 g) 31 (6,2%)
1p value based on Mann-Whitney U test.
2p value based on Student’s t-test.
3p value based on Pearson’s χ2 test.Women in the pregnant group came to the study mainly
from antenatal clinics and two thirds of them were re-
cruited due to their high BMI. Our study subjects are
mainly non-smokers, most of them well educated, with
on average quite good annual household income [44].
Obese women planning pregnancy, especially nullipar-
ous, proved to be difficult to recruit, despite extensive
and repeated recruitment efforts and a long recruitment
time. Therefore the planned total sample size was not
met in non-pregnant group. However, the number of
women recruited should be sufficient to show whetherNon-pregnant
group
Pregnant
group
p Value
Difference between
groups
N = 235 N = 493
1 (0-8) 1 (0-12) 0.0031
1 (0-7) 1 (0-9)
N = 207 N = 304
187 (90,3%) 199 (65,5%) <0,0013
26 (12,6%) 30 (9,9%) 0,343
13 (6,3%) 30 (9,9%) 0,153
64 (30,9%) 93 (30,6%) 0,943
11 (5,3%) 12 (3,9%) 0,463
N = 205 N = 295
14 (6,8%) 28 (9,5%) 0,293
11 (5,4%) 20 (6,8%) 0,523
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http://www.biomedcentral.com/1471-2393/14/70the intervention initiated already in prepregnancy is
more efficient than an intervention initiated in early
pregnancy.
The RADIEL study focuses upon GDM and the impact
of a lifestyle intervention from several different angles:
perinatology, paediatrics, diabetology and neuroen-
docrinology, exercise medicine, genetics, nutrition and
health economics. The mother and child cohort cre-
ates a unique material, which can be followed up for
years to examine the long-term effects of the interven-
tion. The study is expected to produce novel informa-
tion that can easily be applied in primary heath care
systems when selecting interventions and allocating re-
sources to prevent obesity and diabetes in women of
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